TACE could enhance PD-1 and PD-L 1 expression in HCC, and induce tumor cell death with the release of tumoral antigens, proinflammatory cytokines, VEGF, and HIF-1α [18–20]. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.